Z-1660-2022 Class II Ongoing

Recalled by Abbott Laboratories — Abbott Park, IL

FDA device recall Z-1660-2022 was initiated by Abbott Laboratories on Jul 26, 2022 and is designated Class II. Reason for recall: One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component. The recall status is ongoing. Affected quantity: 2451 kits of 100 tests.

Recall Details

Product Type
Devices
Report Date
Sep 7, 2022
Initiation Date
Jul 26, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2451 kits of 100 tests

Product Description

ARCHITECT STAT Troponin-I Reagent Kit, REF 2K41-27

Reason for Recall

One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component.

Distribution Pattern

Nationwide

Code Information

UDI (01) 00380740048525 (17) 991231 (10) 12345M100 (240) 2K4127 Lot lot 63718UN22

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1660-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.